Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015 (2015), Article ID 610605, 13 pages
http://dx.doi.org/10.1155/2015/610605
Research Article

Posterior Cingulate Lactate as a Metabolic Biomarker in Amnestic Mild Cognitive Impairment

1Department of Radiology, University of Washington, P.O. Box 357115, Seattle, WA 98195, USA
2Integrated Brain Imaging Center, University of Washington, Seattle, WA 98195, USA
3Department of Psychosocial and Community Health, University of Washington, Seattle, WA 98195, USA
4Department of Rehabilitation Medicine, University of Washington, Seattle, WA 98195, USA
5Center for Integrative Brain Research, Seattle Children’s Research Institute, Seattle, WA 98101, USA
6Department of Neurology, University of Washington, Seattle, WA 98195, USA

Received 25 June 2014; Accepted 19 October 2014

Academic Editor: Giovanni Li Volti

Copyright © 2015 Kurt E. Weaver et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. Mosconi, A. Pupi, and M. J. de Leon, “Brain glucose hypometabolism and oxidative stress in preclinical Alzheimer's disease,” Annals of the New York Academy of Sciences, vol. 1147, pp. 180–195, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. G. Chételat, B. Desgranges, V. de la Sayette et al., “Dissociating atrophy and hypometabolism impact on episodic memory in mild cognitive impairment,” Brain, vol. 126, no. 9, pp. 1955–1967, 2003. View at Publisher · View at Google Scholar · View at Scopus
  3. S. Yamaguchi, K. Meguro, M. Itoh et al., “Decreased cortical glucose metabolism correlates with hippocampal atrophy in Alzheimer's disease as shown by MRI and PET,” Journal of Neurology, Neurosurgery and Psychiatry, vol. 62, no. 6, pp. 596–600, 1997. View at Publisher · View at Google Scholar · View at Scopus
  4. L. L. Beason-Held, “Dementia and the default mode,” Current Alzheimer Research, vol. 8, no. 4, pp. 361–365, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. L. Wang, P. LaViolette, K. O'Keefe et al., “Intrinsic connectivity between the hippocampus and posteromedial cortex predicts memory performance in cognitively intact older individuals,” NeuroImage, vol. 51, no. 2, pp. 910–917, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. C. Sestieri, M. Corbetta, G. L. Romani, and G. L. Shulman, “Episodic memory retrieval, parietal cortex, and the default mode network: functional and topographic analyses,” Journal of Neuroscience, vol. 31, no. 12, pp. 4407–4420, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. E. M. Reiman, “Fluorodeoxyglucose positron emission tomography: emerging roles in the evaluation of putative Alzheimer's disease-modifying treatments,” Neurobiology of Aging, vol. 32, supplement 1, pp. S44–S47, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. V. T. Marchesi, “Alzheimer's dementia begins as a disease of small blood vessels, damaged by oxidative-induced inflammation and dysregulated amyloid metabolism: implications for early detection and therapy,” The FASEB Journal, vol. 25, no. 1, pp. 5–13, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. A.-L. Lin and D. L. Rothman, “What have novel imaging techniques revealed about metabolism in the aging brain?” Future Neurology, vol. 9, no. 3, pp. 341–354, 2014. View at Google Scholar
  10. C. Iadecola, “Neurovascular regulation in the normal brain and in Alzheimer's disease,” Nature Reviews Neuroscience, vol. 5, no. 5, pp. 347–360, 2004. View at Publisher · View at Google Scholar · View at Scopus
  11. W. Dai, O. L. Lopez, O. T. Carmichael, J. T. Becker, L. H. Kuller, and H. M. Gach, “Mild cognitive impairment and Alzheimer disease: patterns of altered cerebral blood flow at MR imaging,” Radiology, vol. 250, no. 3, pp. 856–866, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. M. J. Mcmanus, M. P. Murphy, and J. L. Franklin, “The mitochondria-targeted antioxidant mitoq prevents loss of spatial memory retention and early neuropathology in a transgenic mouse model of Alzheimer's disease,” Journal of Neuroscience, vol. 31, no. 44, pp. 15703–15715, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. P. H. Reddy, R. Tripathi, Q. Troung et al., “Abnormal mitochondrial dynamics and synaptic degeneration as early events in Alzheimer’s disease: implications to mitochondria-targeted antioxidant therapeutics,” Biochimica et Biophysica Acta, vol. 1822, no. 5, pp. 639–649, 2012. View at Google Scholar
  14. P. E. Sijens, G. P. A. Smit, L. A. Rödiger et al., “MR spectroscopy of the brain in Leigh syndrome,” Brain and Development, vol. 30, no. 9, pp. 579–583, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. R. P. Saneto, S. D. Friedman, and D. W. Shaw, “Neuroimaging of mitochondrial disease,” Mitochondrion, vol. 8, no. 5-6, pp. 396–413, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. A. Schurr, “Lactate: the ultimate cerebral oxidative energy substrate?” Journal of Cerebral Blood Flow & Metabolism, vol. 26, no. 1, pp. 142–152, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. A. Almeida, J. Almeida, J. P. Bolaños, and S. Moncada, “Different responses of astrocytes and neurons to nitric oxide: the role of glycolytically generated ATP in astrocyte protection,” Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 26, pp. 15294–15299, 2001. View at Publisher · View at Google Scholar · View at Scopus
  18. C. Berthet, H. Lei, J. Thevenet, R. Gruetter, P. J. Magistretti, and L. Hirt, “Neuroprotective role of lactate after cerebral ischemia,” Journal of Cerebral Blood Flow and Metabolism, vol. 29, no. 11, pp. 1780–1789, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. D. D. M. Lin, T. O. Crawford, and P. B. Barker, “Proton MR spectroscopy in the diagnostic evaluation of suspected mitochondrial disease,” American Journal of Neuroradiology, vol. 24, no. 1, pp. 33–41, 2003. View at Google Scholar · View at Scopus
  20. E. B. Cady, “Magnetic resonance spectroscopy in neonatal hypoxic-ishaemic insults,” Child's Nervous System, vol. 17, no. 3, pp. 145–149, 2001. View at Publisher · View at Google Scholar · View at Scopus
  21. G. Stoppe, H. Bruhn, P. J. W. Pouwels, W. Hänicke, and J. Frahm, “Alzheimer disease: absolute quantification of cerebral metabolites in vivo using localized proton magnetic resonance spectroscopy,” Alzheimer Disease and Associated Disorders, vol. 14, no. 2, pp. 112–119, 2000. View at Publisher · View at Google Scholar · View at Scopus
  22. T. Ernst, L. Chang, R. Melchor, and C. M. Mehringer, “Frontotemporal dementia and early Alzheimer disease: differentiation with frontal lobe H-1 MR spectroscopy,” Radiology, vol. 203, no. 3, pp. 829–836, 1997. View at Publisher · View at Google Scholar · View at Scopus
  23. V. Govindaraju, K. Young, and A. A. Maudsley, “Proton NMR chemical shifts and coupling constants for brain metabolites,” NMR in Biomedicine, vol. 13, pp. 129–153, 2000. View at Google Scholar
  24. S. R. Dager, N. M. Corrigan, T. L. Richards, and S. Posse, “Research applications of magnetic resonance spectroscopy to investigate psychiatric disorders,” Topics in Magnetic Resonance Imaging, vol. 19, no. 2, pp. 81–96, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. D. P. Soares and M. Law, “Magnetic resonance spectroscopy of the brain: review of metabolites and clinical applications,” Clinical Radiology, vol. 64, no. 1, pp. 12–21, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. S. Minoshima, B. Giordani, S. Berent, K. A. Frey, N. L. Foster, and D. E. Kuhl, “Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease,” Annals of Neurology, vol. 42, no. 1, pp. 85–94, 1997. View at Publisher · View at Google Scholar · View at Scopus
  27. Y. Li, A. P. Chen, J. C. Crane, S. M. Chang, D. B. Vigneron, and S. J. Nelson, “Three-dimensional J-resolved H-1 magnetic resonance spectroscopic imaging of volunteers and patients with brain tumors at 3T,” Magnetic Resonance in Medicine, vol. 58, no. 5, pp. 886–892, 2007. View at Publisher · View at Google Scholar · View at Scopus
  28. M. A. Thomas, L. N. Ryner, M. P. Mehta, P. A. Turski, and J. A. Sorenson, “Localized 2D J-resolved 1H MR spectroscopy of human brain tumors in vivo,” Journal of Magnetic Resonance Imaging, vol. 6, no. 3, pp. 453–459, 1996. View at Publisher · View at Google Scholar · View at Scopus
  29. R. C. Petersen, G. E. Smith, S. C. Waring, R. J. Ivnik, E. G. Tangalos, and E. Kokmen, “Mild cognitive impairment: clinical characterization and outcome,” Archives of Neurology, vol. 56, pp. 303–308, 1999. View at Publisher · View at Google Scholar
  30. M. Grundman, R. C. Petersen, S. H. Ferris et al., “Mild cognitive impairment can be distinguished from Alzheimer disease and normal aging for clinical trials,” Archives of Neurology, vol. 61, no. 1, pp. 59–66, 2004. View at Publisher · View at Google Scholar · View at Scopus
  31. R. C. Petersen, R. Doody, A. Kurz, and etal, “Current concepts in mild cognitive impairment,” Archives of Neurology, vol. 58, pp. 1985–1992, 2001. View at Publisher · View at Google Scholar
  32. N. A. Honeycutt, P. D. Smith, E. Aylward et al., “Mesial temporal lobe measurements on magnetic resonance imaging scans,” Psychiatry Research, vol. 83, no. 2, pp. 85–94, 1998. View at Publisher · View at Google Scholar · View at Scopus
  33. P. E. Barta, L. Dhingra, R. Royall, and E. Schwartz, “Improving sterological estimates for the volume of structures identified in three-dimensional arrays of spatial data,” Journal of Neuroscience Methods, vol. 75, no. 2, pp. 111–118, 1997. View at Publisher · View at Google Scholar · View at Scopus
  34. H. J. G. Gundersen, P. Bagger, T. F. Bendtsen et al., “The new stereological tools: disector, fractionator, nucleator and point sampled intercepts and their use in pathological research and diagnosis,” APMIS, vol. 96, no. 7–12, pp. 857–881, 1988. View at Publisher · View at Google Scholar · View at Scopus
  35. G. H. Glover, T. Q. Li, and D. Ress, “Image-based method for retrospective correction of physiological motion effects in fMRI: RETROICOR,” Magnetic Resonance in Medicine, vol. 44, pp. 162–167, 2000. View at Publisher · View at Google Scholar
  36. C. C. Hanstock, D. L. Rothman, J. W. Prichard, T. Jue, and R. G. Shulman, “Spatially localized 1H NMR spectra of metabolites in the human brain,” Proceedings of the National Academy of Sciences of the United States of America, vol. 85, no. 6, pp. 1821–1825, 1988. View at Publisher · View at Google Scholar · View at Scopus
  37. R. A. E. Edden, A. D. Harris, K. Murphy et al., “Edited MRS is sensitive to changes in lactate concentration during inspiratory hypoxia,” Journal of Magnetic Resonance Imaging, vol. 32, no. 2, pp. 320–325, 2010. View at Publisher · View at Google Scholar · View at Scopus
  38. N. M. Corrigan, T. L. Richards, S. D. Friedman, H. Petropoulos, and S. R. Dager, “Improving 1H MRSI measurement of cerebral lactate for clinical applications,” Psychiatry Research-Neuroimaging, vol. 182, no. 1, pp. 40–47, 2010. View at Publisher · View at Google Scholar · View at Scopus
  39. K. Blennow, “Biomarkers in Alzheimer's disease drug development,” Nature Medicine, vol. 16, no. 11, pp. 1218–1222, 2010. View at Publisher · View at Google Scholar · View at Scopus
  40. P. Chen, G. Ratcliff, S. H. Belle, J. A. Cauley, S. T. DeKosky, and M. Ganguli, “Cognitive tests that best discriminate between presymptomatic AD and those who remain nondemented,” Neurology, vol. 55, no. 12, pp. 1847–1853, 2000. View at Google Scholar · View at Scopus
  41. N. Villain, B. Desgranges, F. Viader et al., “Relationships between hippocampal atrophy, white matter disruption, and gray matter hypometabolism in Alzheimer's disease,” The Journal of Neuroscience, vol. 28, no. 24, pp. 6174–6181, 2008. View at Publisher · View at Google Scholar · View at Scopus
  42. D. S. Margulies, J. L. Vincent, C. Kelly et al., “Precuneus shares intrinsic functional architecture in humans and monkeys,” Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 47, pp. 20069–20074, 2009. View at Publisher · View at Google Scholar · View at Scopus
  43. C. Sorg, V. Riedl, M. Mühlau et al., “Selective changes of resting-state networks in individuals at risk for Alzheimer's disease,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 47, pp. 18760–18768, 2007. View at Publisher · View at Google Scholar
  44. Y. Zhou, J. H. Dougherty Jr., K. F. Hubner, B. Bai, R. L. Cannon, and R. K. Hutson, “Abnormal connectivity in the posterior cingulate and hippocampus in early Alzheimer's disease and mild cognitive impairment,” Alzheimer's and Dementia, vol. 4, no. 4, pp. 265–270, 2008. View at Publisher · View at Google Scholar · View at Scopus
  45. G. Chételat, B. Desgranges, V. De la Sayette, F. Viader, F. Eustache, and J.-C. Baron, “Mild cognitive impairment: can FDG-PET predict who is to rapidly convert to Alzheimer's disease?” Neurology, vol. 60, no. 8, pp. 1374–1377, 2003. View at Publisher · View at Google Scholar · View at Scopus
  46. A. Drzezga, N. Lautenschlager, H. Siebner et al., “Cerebral metabolic changes accompanying conversion of mild cognitive impairment into alzheimer's disease: a PET follow-up study,” European Journal of Nuclear Medicine and Molecular Imaging, vol. 30, no. 8, pp. 1104–1113, 2003. View at Publisher · View at Google Scholar · View at Scopus
  47. C. P. Chi and E. L. Roberts Jr., “Energy substrates for neurons during neural activity: a critical review of the astrocyte-neuron lactate shuttle hypothesis,” Journal of Cerebral Blood Flow and Metabolism, vol. 23, no. 11, pp. 1263–1281, 2003. View at Google Scholar · View at Scopus
  48. J. Prichard, D. Rothman, E. Novotny et al., “Lactate rise detected by 1H NMR in human visual cortex during physiologic stimulation,” Proceedings of the National Academy of Sciences of the United States of America, vol. 88, no. 13, pp. 5829–5831, 1991. View at Publisher · View at Google Scholar · View at Scopus
  49. L. Shalak and J. M. Perlman, “Hypoxic-ischemic brain injury in the term infant-current concepts,” Early Human Development, vol. 80, no. 2, pp. 125–141, 2004. View at Publisher · View at Google Scholar · View at Scopus
  50. P. E. Sijens, P. C. Levendag, C. J. Vecht, P. van Dijk, and M. Oudkerk, “1H MR spectroscopy detection of lipids and lactate in metastatic brain tumors,” NMR in Biomedicine, vol. 9, pp. 65–71, 1996. View at Publisher · View at Google Scholar
  51. G. Aliev, H. H. Palacios, B. Walrafen, A. E. Lipsitt, M. E. Obrenovich, and L. Morales, “Brain mitochondria as a primary target in the development of treatment strategies for Alzheimer disease,” International Journal of Biochemistry and Cell Biology, vol. 41, no. 10, pp. 1989–2004, 2009. View at Publisher · View at Google Scholar · View at Scopus
  52. G. A. Dienel and N. F. Cruz, “Imaging brain activation: simple pictures of complex biology,” Annals of the New York Academy of Sciences, vol. 1147, pp. 139–170, 2008. View at Publisher · View at Google Scholar · View at Scopus
  53. D. J. Selkoe, “Alzheimer's disease is a synaptic failure,” Science, vol. 298, no. 5594, pp. 789–791, 2002. View at Publisher · View at Google Scholar · View at Scopus
  54. M. Kadekaro, A. M. Crane, and L. Sokoloff, “Differential effects of electrical stimulation of sciatic nerve on metabolic activity in spinal cord and dorsal root ganglion in the rat,” Proceedings of the National Academy of Sciences of the United States of America, vol. 82, no. 17, pp. 6010–6013, 1985. View at Publisher · View at Google Scholar · View at Scopus
  55. I. Allaman, M. Gavillet, M. Bélanger et al., “Amyloid-beta aggregates cause alterations of astrocytic metabolic phenotype: impact on neuronal viability,” Journal of Neuroscience, vol. 30, no. 9, pp. 3326–3338, 2010. View at Publisher · View at Google Scholar · View at Scopus
  56. D. J. Rossi, J. D. Brady, and C. Mohr, “Astrocyte metabolism and signaling during brain ischemia,” Nature Neuroscience, vol. 10, no. 11, pp. 1377–1386, 2007. View at Publisher · View at Google Scholar · View at Scopus
  57. P. Bubber, V. Haroutunian, G. Fisch, J. P. Blass, and G. E. Gibson, “Mitochondrial abnormalities in Alzheimer brain: mechanistic implications,” Annals of Neurology, vol. 57, no. 5, pp. 695–703, 2005. View at Publisher · View at Google Scholar · View at Scopus
  58. M. I. Shevell, P. M. Matthews, C. R. Scriver et al., “Cerebral dysgenesis and lactic acidemia: an MRI/MRS phenotype associated with pyruvate dehydrogenase deficiency,” Pediatric Neurology, vol. 11, no. 3, pp. 224–229, 1994. View at Publisher · View at Google Scholar · View at Scopus
  59. J. P. Blass, “A new approach to treating Alzheimer's disease,” Annals of the New York Academy of Sciences, vol. 1147, pp. 122–128, 2008. View at Google Scholar